EMJ Hepatology 13 [Supplement 2] . 2025

In this issue

Primary biliary cholangitis (PBC) experts Thomas Berg, Michael Trauner, and Palak Trivedi discuss the current unmet needs in PBC management, the data behind the recent approval of PPAR agonists elafibranor and seladelpar, and the paradigm changes that they anticipate these drugs will bring to the field.